MedPath

Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline

Not Applicable
Completed
Conditions
Mild Cognitive Decline
Interventions
Dietary Supplement: Dextrose Placebo
Dietary Supplement: Freeze-dried blueberries
Registration Number
NCT01515098
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

Purpose: The purpose of this study is to examine the effect of blueberry consumption on cognitive decline and body composition in humans.

Hypothesis 1: Adults with mild cognitive decline who consume blueberries will experience an improvement in cognitive abilities as measured by a standardized battery of tests, relative to those who consume a placebo.

Hypothesis 2: Adults with mild cognitive decline who consume blueberries will evidence an increase in processing speed and an improvement in memory abilities as measured in an electrophysiological paradigm and compared to those who consume a placebo.

Hypothesis 3: Daily intake of 35 g freeze-dried blueberries will improve body composition (fat mass vs. lean mass).

Hypothesis 4: Daily intake of 35 g freeze-dried blueberries will decrease oxidative stress and inflammatory markers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
123
Inclusion Criteria
  • Men and women age 65 and older
  • BMI between 18.5 and 34.5
  • Close individual to report memory decline
Read More
Exclusion Criteria
  • History of central nervous system or psychiatric disorders
  • Dementia or Alzheimer's diagnosis
  • Diabetes
  • Smoking >20 cigarettes/day
  • Gastrointestinal/digestive disorders
  • Uncontrolled chronic disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo GroupDextrose Placebo37 grams of dextrose powder daily for 6 months
Blueberry GroupFreeze-dried blueberries37 grams of dehydrated blueberries daily for 6 months
Primary Outcome Measures
NameTimeMethod
Change in cognitive test performanceBaseline, 180 days

Measured by CANTAB

Change in brain activity (N200, P300) related to cognitive abilities as measured by event-related potentials (ERP)Baseline, 180 days

Recognition memory, speed of processing, and memory consolidation as measured by the electrophysiological technique known as event-related potentials (ERP)

Secondary Outcome Measures
NameTimeMethod
Change in body mass distributionBaseline, 180 days

DXA scans to measure body composition at baseline and outcome will be compared for differences

Change in oxidative stress and inflammatory markers as measured in blood and urineBaseline, 180 days

Oxidative stress and inflammatory markers will be measured in blood and compared between baseline and outcome.

Trial Locations

Locations (1)

Nutrition Research Institute

🇺🇸

Kannapolis, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath